SMMT Setup: Quiet Now, But That May Change Fast

Summit Therapeutics (SMMT) just popped up on our compression scan, and while the market is pricing in calm, we see a storm brewing. With Phase 3 trial results for its lung cancer drug potentially dropping any day—and Pfizer in the mix—this stock could explode on the right headline.

In today’s newsletter, we break down why volatility is mispriced, what the data tells us about past reactions, and how to position for a major move before May 16th. If you're looking for a catalyst trade with asymmetric potential, this one’s worth a serious look.

Options Decoded is the companion newsletter that provides specific trade ideas to exploit the conditions mentioned in this newsletter. Options Decoded includes FREE bi-weekly coaching sessions as well. If you've already signed up for Options Decoded, check your email for the latest issue.

Market plunge hammering your investments? My account is up a whopping 33.45% this year, and I have the statements to prove it. And now, you can join me for an extremely reasonable price of less than $3 per day. Click on the button below to sign up now.